16 April 2021 : Original article
Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial
DOI: 10.12659/AOT.929535
Ann Transplant 2021; 26:e929535